Negative rapid test results may delay antiviral therapy in patients with severe influenza

June 10, 2018, American Society for Microbiology
influenza
Electron microscopy of influenza virus. Credit: CDC

A new study has found that half of influenza cases in patients admitted to the intensive care unit (ICU) received a false negative rapid influenza antigen test (RIAT). The false negative RIAT results could delay antiviral therapy for patients who were in the ICU with severe influenza. The research is presented at ASM Microbe, the American Society for Microbiology's annual meeting, held from June 7th through 11th in Atlanta, Georgia.

The researchers, led by Po-Yen Huang, MD, Chang-Gung Memoria Hospital, Taoyuan,Taiwan, performed a retrospective analysis of 307 patients with requiring ICU admission at Chang-Gung Memorial Hospital, a tertiary medical center in Taiwan, from August 2009 to July 2017. Of these 307 cases of confirmed influenza, RIAT was performed on 259 with 126 (49%) testing negative. Among the 307 cases, 45 (15%) either tested negative on all upper respiratory tract (URT) samples or did not have URT samples tested. The diagnosis of these 45 cases instead relied on the tests from (LRT) samples.

RIAT is a popular at point-of-care settings since it provides physicians readily available results. A positive test result with its high specificity confirms the diagnosis of influenza. However, a negative test result and its low sensitivity often misleads physicians to exclude the influenza diagnosis. About half of the cases in the study had negative RIAT results. A substantial portion (15%) of the patients were ultimately diagnosed solely by testing lower respiratory tract (LRT) samples. Influenza diagnoses could not be based on the results of RIAT.

"As physicians specialized in infectious disease, we advocate that testing of the LRT samples are crucial for diagnosis of severe influenza with critical illness," said Dr. Huang.

Compared to the RIAT positive , the RIAT negative patients shared similar clinical characteristics except they required longer ICU stays (median 12 vs. 9 days) and longer ventilator days (median 12 vs. 6 days). Furthermore, antiviral treatment was significantly delayed in the RIAT negative patients (median 1 vs. 0 days).

"Negative RIAT results delayed treatment with antiviral medication," said Dr. Huang, MD. "Decision-making for antiviral medication based on RIAT results should be discouraged. Prompt empiric antiviral medication should be provided to all critically ill with severe respiratory infection."

Explore further: Older adults less likely to receive flu tests, according to study

Related Stories

Older adults less likely to receive flu tests, according to study

March 2, 2018
An influenza diagnosis for people 65 and older is serious. Up to 85 percent of influenza-related deaths occur in older adults, the Centers for Disease Control (CDC) and Prevention reports.

Older hospitalized adults are infrequently tested for influenza

January 19, 2018
This year's flu season is shaping up to be an especially serious one, and it's important for clinicians to promptly recognize, diagnosis, and treat influenza in hospitalized patients, especially in vulnerable populations ...

Rapid testing to diagnose influenza leads to more appropriate care in the ED

November 14, 2013
When patients in the emergency department (ED) are diagnosed with influenza by means of a rapid test, they get fewer unnecessary antibiotics, are prescribed antiviral medications more frequently, and have fewer additional ...

Researchers confirm link between flu and heart attack

January 24, 2018
Chances of a heart attack are increased six-fold during the first seven days after detection of laboratory-confirmed influenza infection, according to a new study by researchers at the Institute for Clinical Evaluative Sciences ...

Young, unvaccinated adults account for severest flu cases

February 10, 2014
A snapshot of patients who required care at Duke University Hospital during this year's flu season shows that those who had not been vaccinated had severe cases and needed the most intensive treatment.

Recommended for you

Small-scale poultry farming could mean big problem in developing countries

December 16, 2018
Small-scale farming in developing countries provides those in rural communities with income and access to protein, but it may have a large impact on antibiotic resistance, according to a new University of Michigan study.

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.